Eyes on BMS, Pfizer, & Amgen
top of page
Eyes on Pharma
Check-out What Intel Caught our Eye
Eye's on the Amgen data releases for gMG & Atopic Dermatitis, the BMS approval of Cobenfy for schizophrenia, and Pfizer's Oxbryta recall...
Jana Chisholm
Sep 205 min read
Eyes on BioPharma Headlines
This month, we've had Eyes on investment trends, strategic restructuring, and FDA decisions. Fall seems to be gearing up, and we can't wait
Jana Chisholm
Sep 65 min read
August News Highlights
We've had our Eyes On some of the latest Pharmaceutical news including approvals, partnering, mergers, research programs, and
Jana Chisholm
Aug 116 min read
Eyes On Industry News & Views
News & Views - sharing some oncology, AZD, M&A tidbits that caught our eye.
Jana Chisholm
Jul 175 min read
Eyes On the Competition
his week we've been looking at the competition heating up due to a combination of M&A, biosimilar entrants, and new clinical data ...
Jana Chisholm
Jul 75 min read
Eyes on Oncology, Anti-Virals, and Consumer Products
We've had our Eyes On recent data releases, commercial strategy updates, and some FDA updates. What caught your Eye last week?
Jana Chisholm
Jun 183 min read
Eyes on ASCO 2024
The ASCO 2024 annual meeting took place from 31st May to 4th June. A number of firms presented data, and others used this as an opportunity
jroele
Jun 72 min read
Our Comments & Links on Top 4 Biggest Drugs in 2023
Check out this Top Drugs of 2023 list with links to interesting reports in PharmaTell Studio. Contact us for a trial.
Jana Chisholm
May 185 min read
Eyes on Pharma Restructures + Pfizer's Clinical SAE
We've had Eyes On recent news further clarifying company restructures. In the midst of refining pipelines, and cutting corporate spending ..
Jana Chisholm
May 24 min read
1Q24 BioPharma Deals & Raises
We've been keeping Eyes On Deals & Raises in the BioPharma sector for the first quarter of 2024. Things seem to be heating-up ...
Jana Chisholm
Apr 163 min read
Eyes on Corporate Restructuring
Lately we've been keeping Eyes On the corporate restructuring in the BioPharma sector. We've seen Big Pharma and BioTech refocusing ...
Jana Chisholm
Mar 244 min read
Eyes on Current Events - Deals, Approvals & Operations
We've been trying to keep up with current events - here's some of what we've hay Eyes On this week.
Jana Chisholm
Mar 113 min read
Eyes On Healthcare Headlines
Some of the highlights include AI medical advancements, strategic industry movements, regulatory updates, & challenges within the pharma ...
Jana Chisholm
Feb 83 min read
Eyes on BioPharma Portfolio Strategies
This week we've had Eyes how BioPharma are bolstering their Portfolios for long-term success. From licensing assets ...
Jana Chisholm
Jan 223 min read
Eyes on the New Year - 2024 has a Busy Start with Deals and Approvals
2024 is off to a busy start with M&A activities highlighted at the JP Morgan Healthcare Conference, plus another Genetic Medicines approval.
Jana Chisholm
Jan 107 min read
Eyes on Genetic Medicines & Pipelines
Following up on our previous post about Gene Therapies, we are sharing data on Genetic Medicines in development - pipelines, targets, dates
Jana Chisholm
Jan 27 min read
Eyes on Gene Therapy - The Background
We've been keeping Eyes On the Gene Therapy area - and thought we would post some general information about the area ...
Jana Chisholm
Dec 1, 20233 min read
Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation
The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and
Jana Chisholm
Nov 24, 20233 min read
Eyes on Casgevy, Pfizer & More
Some of this week's news includes Casgevy Approval, Novo's REDEFINE 4 Trial, , new Manufacturing plant and more.
Jana Chisholm
Nov 17, 20233 min read
Eyes On Current Events
While we've been curating 3Q23 Results reports, we've had eyes on drug approvals, Business Development activities, & even some patent ...
bottom of page